Cancer drug targeting.
D000818:Animals; D000906:Antibodies / Q000008:administration & dosage / Q000378:metabolism; D000918:Antibody Specificity; D000951:Antigens, Neoplasm / Q000032:analysis; D000954:Antigens, Surface / Q000032:analysis; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D004351:Drug Resistance; D006801:Humans; D007120:Immunochemistry; D008081:Liposomes / Q000008:administration & dosage; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology; D009928:Organ Specificity
D000906:Antibodies; D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D000970:Antineoplastic Agents; D008081:Liposomes